Table 1 Clinical characteristics of Biobank patients
|  | PDAC n = 63 |  | EC n = 59 |
|---|---|---|---|
Gender n (%) | Â | Gender n (%) | Â |
Male | 32 (51) | Male | 49 (83) |
Female | 31 (49) | Female | 10 (17) |
Age mean (±SD) | 68 (9) | Age mean (±SD) | 64 (11) |
Stage n (%) | Â | Stage n (%) | Â |
I | 4 (6) | I | 4 (6) |
II | 31 (49) | II | 5 (8) |
III | 10 (16) | III | 46 (62) |
IV | 18 (29) | IV | 9 (14) |
Diagnosis n (%) | Â | Diagnosis n (%) | Â |
PDAC | 63 (100) | EAC | 47 (80) |
| Â | Â | ESC | 12 (20) |
Tissue location n (%) | n = 65 (63 patients) | Tissue location n (%) | n = 64 (59 patients) |
Primary tumor | 50 (77) | Biopsy tumor | 35 (55) |
Metastasis | 15 (23) | Resected tumor | 13 (20) |
| Â | Â | Metastasis | 16 (25) |
Grafting outcome n (%) | 47/65 grafted | Grafting outcome n (%) | 61/64 grafted |
Successful | 12 (26) | Successful | 17 (28) |
Unsuccessful | 26 (55) | Unsuccessful | 32 (52) |
Ongoing | 9 (19) | Ongoing | 12 (20) |
Success rate | 12/38 (32%) | Success rate | 17/49 (35%) |
(excl. ongoing grafts) | Â | EAC | 13/39 (33%) |
| Â | Â | ESC | 4/10 (25%) |
| Â | Â | (excl. ongoing grafts) | Â |